MedTrace Logo

Cancer-related Venous Thromboembolic Disease - Cohort Study

NCT06393764 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2024-11-06

No results posted yet for this study

Summary

Venous thromboembolic disease (VTE) is a common (1/1000), potentially serious disease (10% mortality when the clinical presentation is that of pulmonary embolism (PE)). In cancer patients, the risk of developing VTE is high and constitutes a negative prognostic factor for cancer; the risk of bleeding is also increased. The study of VTE in the context of cancer is a major challenge, given the frequency of the association, the heterogeneity of the situations, the risk factors involved and the therapeutic issues in both curative and primary prevention; in this field, many uncertainties remain, justifying a study focused on the association of VTE and cancer.

Conditions

  • Thrombosis Embolism
  • Thromboses, Venous
  • Cancer

Interventions

OTHER

Collection of biological samples

Collecte of blood and urine samples

Sponsors & Collaborators

  • University Hospital, Brest

    lead OTHER

Principal Investigators

  • Françis Couturaud, Pr · CHU Brest

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-30
Primary Completion
2034-11-30
Completion
2034-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06393764 on ClinicalTrials.gov